Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control design

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Krown, Susan E, Fingleton, Barbara, Lee, Jeannette Y, Egorin, Merrill J, Koon, Henry B
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2010
Pynciau:
Meeting Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002724/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-9378-5-S1-A62
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg